12-111456268-C-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_001372574.1(ATXN2):​c.3043-12G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.208 in 1,613,538 control chromosomes in the GnomAD database, including 36,117 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.20 ( 3228 hom., cov: 33)
Exomes 𝑓: 0.21 ( 32889 hom. )

Consequence

ATXN2
NM_001372574.1 intron

Scores

2
Splicing: ADA: 0.00002213
2

Clinical Significance

Benign criteria provided, single submitter B:3

Conservation

PhyloP100: -1.76

Publications

22 publications found
Variant links:
Genes affected
ATXN2 (HGNC:10555): (ataxin 2) This gene belongs to a group of genes that is associated with microsatellite-expansion diseases, a class of neurological and neuromuscular disorders caused by expansion of short stretches of repetitive DNA. The protein encoded by this gene has two globular domains near the N-terminus, one of which contains a clathrin-mediated trans-Golgi signal and an endoplasmic reticulum exit signal. The encoded cytoplasmic protein localizes to the endoplasmic reticulum and plasma membrane, is involved in endocytosis, and modulates mTOR signals, modifying ribosomal translation and mitochondrial function. The N-terminal region of the protein contains a polyglutamine tract of 14-31 residues that can be expanded in the pathogenic state to 32-200 residues. Intermediate length expansions of this tract increase susceptibility to amyotrophic lateral sclerosis, while long expansions of this tract result in spinocerebellar ataxia-2, an autosomal-dominantly inherited, neurodegenerative disorder. Genome-wide association studies indicate that loss-of-function mutations in this gene may be associated with susceptibility to type I diabetes, obesity and hypertension. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
ATXN2 Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 12-111456268-C-T is Benign according to our data. Variant chr12-111456268-C-T is described in ClinVar as Benign. ClinVar VariationId is 522365.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.318 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATXN2NM_001372574.1 linkc.3043-12G>A intron_variant Intron 22 of 24 ENST00000673436.1 NP_001359503.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATXN2ENST00000673436.1 linkc.3043-12G>A intron_variant Intron 22 of 24 NM_001372574.1 ENSP00000500925.1

Frequencies

GnomAD3 genomes
AF:
0.202
AC:
30760
AN:
151972
Hom.:
3227
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.194
Gnomad AMI
AF:
0.151
Gnomad AMR
AF:
0.177
Gnomad ASJ
AF:
0.109
Gnomad EAS
AF:
0.330
Gnomad SAS
AF:
0.267
Gnomad FIN
AF:
0.185
Gnomad MID
AF:
0.310
Gnomad NFE
AF:
0.206
Gnomad OTH
AF:
0.215
GnomAD2 exomes
AF:
0.210
AC:
52837
AN:
251260
AF XY:
0.213
show subpopulations
Gnomad AFR exome
AF:
0.193
Gnomad AMR exome
AF:
0.166
Gnomad ASJ exome
AF:
0.113
Gnomad EAS exome
AF:
0.320
Gnomad FIN exome
AF:
0.184
Gnomad NFE exome
AF:
0.206
Gnomad OTH exome
AF:
0.214
GnomAD4 exome
AF:
0.209
AC:
305612
AN:
1461446
Hom.:
32889
Cov.:
32
AF XY:
0.210
AC XY:
152638
AN XY:
726990
show subpopulations
African (AFR)
AF:
0.189
AC:
6321
AN:
33470
American (AMR)
AF:
0.164
AC:
7316
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.109
AC:
2859
AN:
26134
East Asian (EAS)
AF:
0.279
AC:
11075
AN:
39692
South Asian (SAS)
AF:
0.273
AC:
23576
AN:
86248
European-Finnish (FIN)
AF:
0.189
AC:
10080
AN:
53406
Middle Eastern (MID)
AF:
0.327
AC:
1883
AN:
5764
European-Non Finnish (NFE)
AF:
0.206
AC:
229474
AN:
1111626
Other (OTH)
AF:
0.216
AC:
13028
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
14549
29098
43648
58197
72746
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8018
16036
24054
32072
40090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.202
AC:
30771
AN:
152092
Hom.:
3228
Cov.:
33
AF XY:
0.201
AC XY:
14950
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.194
AC:
8047
AN:
41460
American (AMR)
AF:
0.177
AC:
2704
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.109
AC:
379
AN:
3470
East Asian (EAS)
AF:
0.331
AC:
1712
AN:
5176
South Asian (SAS)
AF:
0.267
AC:
1287
AN:
4822
European-Finnish (FIN)
AF:
0.185
AC:
1957
AN:
10582
Middle Eastern (MID)
AF:
0.303
AC:
89
AN:
294
European-Non Finnish (NFE)
AF:
0.206
AC:
14008
AN:
67978
Other (OTH)
AF:
0.213
AC:
450
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1259
2518
3776
5035
6294
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
338
676
1014
1352
1690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.204
Hom.:
9438
Bravo
AF:
0.202
Asia WGS
AF:
0.299
AC:
1041
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Spinocerebellar ataxia type 2 Benign:1
Oct 05, 2015
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.55
DANN
Benign
0.64
PhyloP100
-1.8
PromoterAI
-0.0090
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000022
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2073950; hg19: chr12-111894072; COSMIC: COSV57983646; COSMIC: COSV57983646; API